A method utilizing immobilized major group rhinoviruses and biotinylated soluble intercellular adhesion molecule 1 has been developed for the detection of capsid binders. Binding measurements indicate a loss in relative affinity of biotinylated soluble intercellular adhesion molecule 1 for rhinoviruses by capsid binders. This method and a new class of capsid binders are discussed.
dia, and the plates were incubated for 72 h at 33°C. After being incubated, the plates were visually inspected for CPE and processed as previously reported (5) .
The compound AZAX0067 (Fig. 1A) Previous studies showed that when sICAM-1 is biotinylated it is functionally active and equivalent to the nonbiotinylated molecule in CPE assays (5) . In addition, sICAM-1 competes with biotinylated sICAM-1 in the RVB ELISA ( Fig. 2A) . The relative affinities of both sICAM-1 and There are several compounds which are known to bind to picornavirus capsid proteins and inhibit virus replication. Table 1 shows data from an RVB ELISA in which one, WIN54954, inhibits the binding of biotinylated sICAM-1 to HRV-34 and HRV-54. The isotherms of the competitive binding assays between WIN54954 and biotinylated sI-CAM-1 for HRV-54 and HRV-34 are shown in Fig. 2B . WIN54954 decreases the affinity of the virus for biotinylated sICAM-1; that of HRV-54 went from 5.6 x 106 to 4.9 x 103 (liters mole-'), and that of HRV-34 went from 1.7 x 107 to 6.7 x 104 (liters mole-1).
Since capsid binders can alter the affinities of sICAM-1 to major group HRVs, we investigated the usefulness of this system for discovering additional capsid binders. Utilizing the RVB ELISA, we discovered 3 of 10,000 randomly screened diverse compounds to inhibit binding of biotinylated sICAM-1 to HRV-54. The first of these belonged to the phenoxypyridazinamine series of inhibitors, and the second belonged to the chalcone series of inhibitors (for a review, see reference 1). Table 2 shows the effects of these compounds in the functional CPE heating, 85% CPE was observed. This is in contrast to the non-compound-treated, heated virus group, in which only 5% CPE occurred. CPE was observed in all control groups. The primary mechanism of action of capsid binders is to inhibit uncoating of the virion by binding in the canyon of the capsid proteins (1-3, 7). It has also been shown previously that some of these compounds may inhibit the binding of the virion to its receptor (8) . Data from the RVB ELISA also support this idea. Results reflect changes of HRV affinity for sICAM-1 by capsid binders including WIN54954 and the newly discovered compound AZAX0067. Both compounds inhibited the binding of HRV-54 and HRV-34 to sICAM-1, resulting in a loss in affinity.
This method, together with a previous report (5), proves and further highlights the utility of soluble receptors as reagents and tools for the diagnosis and discovery of new inhibitors.
